Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.

Key facts

Study ID

NCT00671749

Run by

Galderma R&D

People needed

100

Starts

2007-12-01

Expected to finish

2008-08-01

Last updated by the study team

2022-08-23

Who can join

Age: 12 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with a minimum of 20 inflammatory lesions on the face;
• Subjects with a minimum of 15 and a maximum of 100 non-inflammatory lesions (open and closed comedones) on the face, excluding the nose;
• Subject has a Global Severity Assessment

You may not qualify if…

• Subjects with more than three nodulo-cystic lesions

Where it is running

• Center for Dermatology and Laser Surgery — Sacramento, California, United States
• Derm Research, P.L.L.C. — Louisville, Kentucky, United States
• Brodell Medical — Warren, Ohio, United States
• Northwest Cutaneous Research Specialists — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.